Abstract
Some obese individuals do not get cardiovascular disease, diabetes, or certain cancers associated with obesity. These healthy obese individuals exercise regularly and reduce circulating levels of inflammatory mediators which are associated with the complications of obesity. Bloated white adipocytes located in ectopic locations such as the liver, produce these inflammatory mediators. Exercise, by reducing the excess storage of fat in these bloated fat cells, reduces the levels of circulating inflammatory mediators. The processes of gathering and creating new energy-rich substances, storing energy, and consuming energy-rich substances, and the specific contribution of several hormones to this process, are reviewed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stefan N et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Int Med 168:1607–1616
Mora S et al (2006) Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 295:1412–1419
Allende-Vigo MZ (2010) Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr Pract 16:602–608
Bays HE et al (2008) Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6:343–368
Majka S et al (2011) Concise review: Adipocyte origins: weighing the possibilities. Stem Cells 29:1034–1040
Woods S et al (2006) Baylor College of Medicine Reports on Cardiometabolic Disorders 1:206, 1–10
Breivogel CS et al (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5:417–433
Yamauchi T et al (2002) Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP activated protein kinase. Nat Med 8:1288–1295
Engeli S et al (2005) activation of the peripheral endocannabinoid system in human obesity. Diabetes 54:2838–2843
Osei-Hyiaman D et al (2005) Endocannabinoid activation at hepatic CB 1 receptors stimulates fatty acid synthesis and contributes to diet induced obesity. JCI 115:1298–1305
Liu YL et al (2005) Effects of the cannabinoid CB 1 receptor antagonist SR1411716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int J Obes 29:183–187
Powers SK, Howley ET (2009) Exercise Physiology. Chapter 5, Mcgraw Hill, New York
Gaidhu MP et al (2012) Role of adenosine monophosphate kinase in remodeling white adipose tissue metabolism. Exerc Sport Sci Rev 39:102–108
Wang T (2012) The Natriuretic peptides and fat metabolism. NEJM 367:377–378
Chandalia M et al (2012) Adipose tissue dysfunction in Humans: a potential role for the transmembrane protein ENPP1. JCEM 97:4663–4672
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergman, D. The endocrinology of exercise. Intern Emerg Med 8 (Suppl 1), 17–21 (2013). https://doi.org/10.1007/s11739-013-0921-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-013-0921-2